CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Previously Reported	Revision of Prior Period, Adjustment	Common stock	Common stock Common stock	Common stock Common stock Previously Reported	Common stock Class A	Common stock Class A Previously Reported	Common stock Class A Revision of Prior Period, Adjustment	Common stock Class C	Common stock Class C Previously Reported	Common stock Class C Revision of Prior Period, Adjustment	Preferred Stock Class B Preferred	Preferred Stock Class B Preferred Previously Reported	Preferred Stock Class B Preferred Revision of Prior Period, Adjustment	Preferred Stock Class B-1 Preferred	Preferred Stock Class B-1 Preferred Previously Reported	Preferred Stock Class B-1 Preferred Revision of Prior Period, Adjustment	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Additional paid-in capital Previously Reported	Additional paid-in capital Revision of Prior Period, Adjustment	Accumulated other comprehensive loss	Accumulated other comprehensive loss Previously Reported	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment	Accumulated deficit Previously Reported
Beginning balance (in shares) at Dec. 31, 2019						0	0	27,156,000	2,581,000	24,575,000	4,061,000	436,000	3,625,000	18,388,000	1,728,000	16,660,000	9,300,000	630,000	8,670,000
Beginning balance at Dec. 31, 2019	$ 2,380		$ 2,380	$ 0		$ 0	$ 0	$ 27	$ 387	$ (360)	$ 4	$ 4,054	$ (4,050)	$ 18	$ 1,898	$ (1,880)	$ 9	$ 23,656	$ (23,647)	$ 30,044		$ 107	$ 29,937	$ 0	$ 0	$ (27,722)		$ (27,722)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06 [Member]
Issuance of common stock (in shares)								10,842,000			370,000			2,240,000			7,022,000
Issuance of common stock	$ 125,676							$ 11						$ 3			$ 7			125,655
Unrealized loss on debt securities available for sale	0
Net loss	(52,992)																									(52,992)
Issuance of units upon vesting of Legacy PCT profits interests (in shares)											2,288,000
Issuance of units upon vesting of Legacy PCT profits interests	5,626										$ 3									5,623
Redemption of vested profit units (in shares)											(8,000)
Redemption of vested profit units	(16)																			(16)
Beneficial conversion feature upon issuance of convertible notes	31,075																			31,075
Ending balance (in shares) at Dec. 31, 2020						0	0	37,998,000	3,612,000	34,386,000	6,711,000	775,000	5,936,000	20,628,000	1,938,000	18,690,000	16,322,000	1,105,000	15,217,000
Ending balance at Dec. 31, 2020	111,749	$ (30,638)	$ 111,749	$ 0		$ 0	$ 0	$ 38	$ 88,081	$ (88,043)	$ 7	$ 11,967	$ (11,960)	$ 21	$ 20,071	$ (20,050)	$ 16	$ 41,162	$ (41,146)	192,381	$ (31,075)	$ 31,182	$ 161,199	0	$ 0	(80,714)	$ 437	$ (80,714)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)						236,000
Issuance of common stock	1,000					$ 1														999
Forfeiture of restricted stock (in shares)						(23,000)
Stock repurchase (in shares)						(131,000)
Share repurchase	(1,695)																			(1,695)
Equity based compensation (in shares)						31,000
Equity based compensation	22,730																			22,730
Unrealized loss on debt securities available for sale	(237)																							(237)
Net loss	$ (77,502)																									(77,502)
Issuance of units upon vesting of Legacy PCT profits interests (in shares)	0										116,000
Issuance of units upon vesting of Legacy PCT profits interests	$ 239																			239
Redemption of vested profit units (in shares)											(5,000)
Redemption of vested profit units	(36)																			(36)
Merger Recapitalization (in shares)						81,754,000		37,998,000			6,822,000			20,628,000			16,322,000
Merger Recapitalization	0					$ 82		$ (38)			$ (7)			$ (21)			$ (16)
ROCH Shares Recapitalized, Net of Redemptions, Warrant Liability and Issuance Costs of $27.9 million (in shares)						34,823,000
ROCH Shares Recapitalized, Net of Redemptions, Warrant Liability and Issuance Costs of $27.9 million	293,966					$ 35														293,931
Issuance of shares upon conversion of Convertible Notes (in shares)						9,165,000
Issuance of shares upon conversion of Convertible Notes	61,796					$ 9														61,787
Issuance of restricted stock awards (in shares)						1,775,000
Issuance of restricted stock awards	0					$ 2														(2)
Exercise of warrants (in shares)						17,000
Exercise of warrants	196																			196
Forfeiture of restricted stock	0					$ (1)														1
Reclassification of redeemable warrant to liability	(33)																			(33)
Ending balance (in shares) at Dec. 31, 2021						127,647,000		0			0			0			0
Ending balance at Dec. 31, 2021	381,535					$ 128		$ 0			$ 0			$ 0			$ 0			539,423				(237)		(157,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)						35,714,000
Issuance of common stock	205,296					$ 35														205,261
Forfeiture of restricted stock (in shares)					(33,000)
Stock repurchase (in shares)						(212,000)
Share repurchase	(1,639)																			(1,639)
Equity based compensation (in shares)						434,000
Equity based compensation	10,841				$ 1															10,840
Unrealized loss on debt securities available for sale	(404)																							(404)
Net loss	$ (84,746)																									(84,746)
Issuance of units upon vesting of Legacy PCT profits interests (in shares)	0
Ending balance (in shares) at Dec. 31, 2022						163,550,000		0			0			0			0
Ending balance at Dec. 31, 2022	$ 510,883					$ 164		$ 0			$ 0			$ 0			$ 0			$ 753,885				$ (641)		$ (242,525)